A systematic review of clinically available gene expression profiling assays for stage II colorectal cancer: initial steps toward genetic staging
- 1 October 2016
- journal article
- review article
- Published by Elsevier in The American Journal of Surgery
- Vol. 212 (4) , 700-714
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian seriesAnnals of Oncology, 2012
- Generation and external validation of a tumor‐derived 5‐gene prognostic signature for recurrence of lymph node‐negative, invasive colorectal carcinomaCancer, 2012
- Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal CancerJournal of Clinical Oncology, 2011
- Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus LeucovorinJournal of Clinical Oncology, 2010
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon CancerJournal of Clinical Oncology, 2010
- Experimentally Derived Metastasis Gene Expression Profile Predicts Recurrence and Death in Patients With Colon CancerGastroenterology, 2010
- Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal CancerClinical Cancer Research, 2009
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002